Immunosuppression in Patients With High-Grade Gliomas Treated With Radiation and Temozolomide

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-0774
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cognitive Impairments in Patients With Low Grade Gliomas and High Grade Gliomas

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2011English

Impact of Glycemia on Survival of Glioblastoma Patients Treated With Radiation and Temozolomide

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2015English

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Turk Onkoloji Dergisi
Oncology
2019English

Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma

New England Journal of Medicine
Medicine
2017English

Pcn65 - Long- Term Survival Among Patients With High-Grade Glioma Treated With Nimotuzumab

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Low-Grade Gliomas in Older Patients

Cancer
Cancer ResearchOncology
2009English

A 4-Gene Signature Associated With Clinical Outcome in High-Grade Gliomas

Clinical Cancer Research
Cancer ResearchOncology
2011English

High-Grade Gliomas in Children With Neurofibromatosis Type 1: Literature Review and Illustrative Cases

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy